https://www.selleckchem.com/pr....oducts/epz011989.htm
on has an impact on the outcome of assisted reproductive therapy. It has been more than 10 years since the human papillomavirus (HPV) vaccination program was initiated in most advanced countries. Thus, it seems necessary to change the uterine cervical cancer screening strategy. Molecular-based tests are considered essential in this scenario. We aimed to review the distribution of the HPV genotypes after the introduction of the vaccination program with Cervarix® and Gardasil 4® in two autonomous communities in Spain, looking for possib
Aimer
Commentaire
Partagez
